Michael M. Derkacz
Chief Executive Officer at BRAEBURN INC.
Michael M. Derkacz active positions
Companies | Position | Start | End |
---|---|---|---|
BRAEBURN INC. | Director/Board Member | 05/06/2017 | - |
Chief Executive Officer | 05/06/2017 | - | |
President | 05/06/2017 | - |
Career history of Michael M. Derkacz
Former positions of Michael M. Derkacz
Companies | Position | Start | End |
---|---|---|---|
AUSPEX PHARMACEUTICALS INC | Corporate Officer/Principal | 05/05/2015 | - |
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Corporate Officer/Principal | - | - |
TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 01/01/2011 | - |
Training of Michael M. Derkacz
The University of Texas at Austin | Undergraduate Degree |
Statistics
International
United States | 5 |
Israel | 2 |
Operational
Corporate Officer/Principal | 3 |
Undergraduate Degree | 1 |
Director/Board Member | 1 |
Sectoral
Health Technology | 4 |
Consumer Services | 2 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
Private companies | 3 |
---|---|
Auspex Pharmaceuticals, Inc.
Auspex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Auspex Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm focuses on the development and commercialization of novel medicines for the treatment of orphan diseases. The company was founded by Sepehr Sarshar, Thomas G. Gant and Manouchehr M. Shahbaz on February 28, 2001 and is headquartered in San Diego, CA. | Health Technology |
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Health Technology |
Braeburn, Inc.
Braeburn, Inc. Miscellaneous Commercial ServicesCommercial Services Braeburn, Inc. manufactures pharmaceutical products. It focuses on novel, long-acting implantable and injectable therapies for serious neurological and psychiatric disorders, including addiction, pain and schizophrenia. The firm develops Probuphine for the treatment of adult patients with opioid dependence. The company was founded in 2012 and is headquartered in Princeton, NJ. | Commercial Services |
- Stock Market
- Insiders
- Michael M. Derkacz
- Experience